At the same time, the pleiotropic, neurotrophic and neuroprotective properties of GLP-1RAs are also obvious and, taking into account the ability to enhance the energy metabolism of neurons and optimize synaptic plasticity these beneficial effects position GLP-1RAs as potential agents modifying brain diseases [109, 110]
Not enough insurers signed on for the voluntary plan by the April deadline, so CMS instead announced it would extend the Bridge program to 18 months, with a new end date of December 2027
Younger adults were the most aware Adults aged 18-24 reported the highest awareness levels, with more than a quarter ( 25.92% ) saying they knew about the upcoming launch
Under the influence of estrogen, fat is preferentially stored in subcutaneous depots, beneath the skin, particularly around the hips and thighs
Q5: Which region will dominate the GLP-1 Analogues market